Healthcare provider profile · identity verified

Madbel Teijeiro, APRN

Nurse Practitioner · HIALEAH, FL · NPI 1386260420

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	685	227
Losartan Potassium	Losartan Potassium	451	140
Omeprazole	Omeprazole	357	107
Metformin Hcl	Metformin Hcl	337	103
Gabapentin	Gabapentin	321	91
Rosuvastatin Calcium	Rosuvastatin Calcium	290	95
Famotidine	Famotidine	289	79
Vitamin D2	Ergocalciferol (Vitamin D2)	267	75
Amlodipine Besylate	Amlodipine Besylate	229	78
Albuterol Sulfate Hfa	Albuterol Sulfate	222	52
Lisinopril	Lisinopril	206	69
Metoprolol Succinate	Metoprolol Succinate	204	64
Hydrochlorothiazide	Hydrochlorothiazide	194	56
Ketoconazole	Ketoconazole	185	51
Simvastatin	Simvastatin	183	52
Pantoprazole Sodium	Pantoprazole Sodium	181	52
Diclofenac Sodium	Diclofenac Sodium	177	87
Levothyroxine Sodium	Levothyroxine Sodium	171	56
Fluticasone Propionate	Fluticasone Propionate	164	39
Alendronate Sodium	Alendronate Sodium	157	32
Tamsulosin Hcl	Tamsulosin Hcl	152	54
Ammonium Lactate	Ammonium Lactate	145	40
Furosemide	Furosemide	144	44
Alcohol Prep Pads	Alcohol Antiseptic Pads	141	35
Montelukast Sodium	Montelukast Sodium	134	37
Glipizide	Glipizide	124	34
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	121	33
Eliquis	Apixaban	118	27
Trazodone Hcl	Trazodone Hcl	118	31
Azithromycin	Azithromycin	108	88
Carvedilol	Carvedilol	105	33
Clopidogrel	Clopidogrel Bisulfate	100	33
Memantine Hcl	Memantine Hcl	98	38
Enalapril Maleate	Enalapril Maleate	96	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	91	80
Meloxicam	Meloxicam	89	60
Januvia	Sitagliptin Phosphate	87	15
Nifedipine Er	Nifedipine	86	21
Mupirocin	Mupirocin	85	42
Metoprolol Tartrate	Metoprolol Tartrate	84	28
Cyproheptadine Hcl	Cyproheptadine Hcl	81	21
Folic Acid	Folic Acid	81	26
Lactulose	Lactulose	80	24
Triamcinolone Acetonide	Triamcinolone Acetonide	75	27
Baclofen	Baclofen	74	62
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	25
Ibuprofen	Ibuprofen	70	48
Jardiance	Empagliflozin	69	14
Sildenafil Citrate	Sildenafil Citrate	69	16
Donepezil Hcl	Donepezil Hcl	68	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	66	18
Allopurinol	Allopurinol	64	17
Vascepa	Icosapent Ethyl	63	13
Atenolol	Atenolol	62	23
Azelastine Hcl	Azelastine Hcl	59	22
Glipizide Er	Glipizide	58	18
Xarelto	Rivaroxaban	58	11
Clonidine Hcl	Clonidine Hcl	56	15
Ciclopirox	Ciclopirox	54	16
Mirtazapine	Mirtazapine	53	19
Sertraline Hcl	Sertraline Hcl	53	14
Tadalafil	Tadalafil	52	14
Hydralazine Hcl	Hydralazine Hcl	50	13
Meclizine Hcl	Meclizine Hcl	50	26
Farxiga	Dapagliflozin Propanediol	49	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	48	38
Linzess	Linaclotide	48	12
Hydrocortisone	Hydrocortisone	45	18
Pioglitazone Hcl	Pioglitazone Hcl	45	17
Prednisone	Prednisone	45	15
Sucralfate	Sucralfate	45	11
Entresto	Sacubitril/Valsartan	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	12
Levofloxacin	Levofloxacin	40	35
Clobetasol Propionate	Clobetasol Propionate	39	14
Glimepiride	Glimepiride	39	15
Nitroglycerin	Nitroglycerin	38	suppressed
Synjardy	Empagliflozin/Metformin Hcl	38	suppressed
Ciclopirox	Ciclopirox Olamine	36	12
Ezetimibe	Ezetimibe	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	13
Myrbetriq	Mirabegron	32	suppressed
Repaglinide	Repaglinide	31	14
Wixela Inhub	Fluticasone Propion/Salmeterol	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	12
Fenofibrate	Fenofibrate	27	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Megestrol Acetate	Megestrol Acetate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Ozempic	Semaglutide	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Loperamide	Loperamide Hcl	23	11
Clotrimazole	Clotrimazole	22	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	21	16
Latanoprost	Latanoprost	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Dutasteride	Dutasteride	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Colchicine	Colchicine	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	14
Pentoxifylline	Pentoxifylline	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Trulicity	Dulaglutide	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Methocarbamol	Methocarbamol	16	13
Mometasone Furoate	Mometasone Furoate	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Finasteride	Finasteride	14	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Temazepam	Temazepam	14	suppressed
Travoprost	Travoprost	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Torsemide	Torsemide	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetic Acid	Acetic Acid	12	suppressed
Gemtesa	Vibegron	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error